- Home
- Publications
- Publication Search
- Publication Details
Title
Roles for lysophospholipid S1P receptors in multiple sclerosis
Authors
Keywords
-
Journal
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
Volume 46, Issue 1, Pages 2-10
Publisher
Informa UK Limited
Online
2010-10-28
DOI
10.3109/10409238.2010.522975
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fingolimod (FTY720) Enhances Remyelination Following Demyelination of Organotypic Cerebellar Slices
- (2010) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor
- (2010) D. Zhu et al. BLOOD
- Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
- (2010) Jerold Chun et al. CLINICAL NEUROPHARMACOLOGY
- S1P1 receptor directs the release of immature B cells from bone marrow into blood
- (2010) Maria L. Allende et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Multiple sclerosis: Closing in on an oral treatment
- (2010) Roland Martin NATURE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- T-bet–dependent S1P5expression in NK cells promotes egress from lymph nodes and bone marrow
- (2009) Craig N. Jenne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning
- (2009) Trung H.M. Pham et al. JOURNAL OF EXPERIMENTAL MEDICINE
- FTY720 ameliorates MOG-induced experimental autoimmune encephalomyelitis by suppressing both cellular and humoral immune responses
- (2009) Dimitrios Papadopoulos et al. JOURNAL OF NEUROSCIENCE RESEARCH
- FTY720 Reduces Inflammation and Promotes Functional Recovery after Spinal Cord Injury
- (2009) Kangmin D. Lee et al. JOURNAL OF NEUROTRAUMA
- Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors
- (2009) Florian Mullershausen et al. Nature Chemical Biology
- Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia
- (2009) D. Nayak et al. NEUROSCIENCE
- Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats
- (2009) Yu Hasegawa et al. STROKE
- Cyclical and Dose-Dependent Responses of Adult Human Mature Oligodendrocytes to Fingolimod
- (2008) Veronique E. Miron et al. AMERICAN JOURNAL OF PATHOLOGY
- FTY720 Rescue Therapy in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis: Expression of Central Nervous System Genes and Reversal of Blood-Brain-Barrier Damage
- (2008) Carolyn A. Foster et al. BRAIN PATHOLOGY
- Astrocytes in multiple sclerosis: A product of their environment
- (2008) A. Nair et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
- (2008) Yun-Ping Wu et al. HUMAN MOLECULAR GENETICS
- Accumulation of Fingolimod (FTY720) in Lymphoid Tissues Contributes to Prolonged Efficacy
- (2008) S.-C. Sensken et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of natural killer cells in the pathogenesis and progression of multiple sclerosis
- (2007) Barbara Morandi et al. PHARMACOLOGICAL RESEARCH
- Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
- (2007) Kumlesh K. Dev et al. PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search